The Hospitalists' Perspective: Evidence-Based Strategies for Inpatient Anemia CME
Aryeh Shander, MD, FCCM, FCCP; Richard K. Spence, MD, FACS; Alpesh Amin, MD, MBA, FACP
Disclosures

Release Date: June 30, 2006Valid for credit through June 30, 2007


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "The Hospitalists' Perspective: Evidence-Based Strategies for Inpatient Anemia" symposium held at the Hilton Washington in Washington, DC on May 3, 2006.

Contents of This CME Activity

Disclaimer

Erythropoetin stimulating agents will be discussed within this symposium. The FDA has recently added warnings to the prescribing information on these products. Please check current full prescribing information and refer to the FDA website for updates: http://www.fda.gov/cder/drug/infopage/RHE/default.htm
This activity is offered in two formats. Please choose one of the versions:

    Slides and Audio Version
    (A multimedia presentation with synchronized audio, slides and transcript.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript:

  1. Introduction
    by Aryeh Shander, MD, FCCP, FCCM
    Impact of Anemia

  2. Cost-Benefit of Anemia Management
    by Richard K. Spence, MD, FACS
    Prevalence of Anemia
    Factors Associated With Anemia in the Hospitalized Patient
    Anemia and Its Outcomes
    Use of Allogeneic Blood/Blood Products and Outcomes
    Anemia in Heart Failure
    Anemia and Response to Treatment
    Admission Hemoglobin Levels and Outcomes
    Conclusions

  3. Evidence-Based Clinical Approaches to Cancer-Induced Anemia Management
    by Alpesh Amin, MD, MBA, FACP
    Anemia in Chronic Disease and Its Impact
    Anemia in Cancer
    Treatment Options in Anemia in Cancer
    Blood Transfusion in Critical Care
    Anemia and Blood Transfusion in Critical Care
    Use of Erythropoietin in the Critically Ill
    Use of Preoperative Erythropoietin
    Conclusions

  4. Perioperative Anemia Management for Improved Medical and Economic Outcomes
    by Aryeh Shander, MD, FCCP, FCCM
    Anemia Management Is Important, Clinically and Economically
    Risks of Anemia
    Risks of Anemia (cont'd)
    Risks and Complications of Transfusions
    Use (and Misuse) of Fresh Frozen Plasma
    Transfusion Practices Vary
    Prevalence of Anemia in the Surgical Patient: Optimizing Care
    Clinical Care Pathways for Anemia in the Surgical Patient
    The Economics of Transfusions
    Pharmacologic Treatment of Anemia
    Conclusions


Take this program with you!
Download this Web Conference as an MP3 and load it onto your iPod or other portable audio player for audio CME on-the-go.
audio MP3 Audio file Aryeh Shander, MD, FCCP, FCCM
MP3 Audio file Richard K. Spence, MD, FACS
MP3 Audio file Alpesh Amin, MD, MBA, FACP
MP3 Audio file Aryeh Shander, MD, FCCP, FCCM
(Right-click and select "Save Target As…" to download)
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 
Copyright © 2006 The Mount Sinai School of Medicine.



Ortho Biotech

  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
 
Mt. Sinai School of Medicine
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of Mount Sinai School of Medicine.

The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Mount Sinai School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.